Skip to main content

Find Clinical Trials

Home
Conditions
Morbillivirus Infections

Clinical trial condition

Morbillivirus Infections

Explore clinical trials studying Morbillivirus Infections. Study availability and eligibility vary by location and protocol.

100 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Morbillivirus Infections trial results

Not Yet Recruiting

Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months

NCT06815835

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +14 more
Locations: Icddr,B Dhaka, Bangladesh

View Trial Details

Completed

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR

NCT02325310

Conditions: Infections, Measles, Mononegavirales Infections, +14 more
Locations: Cochin Port Royal Hospital - Centre d'Investigation Clinique Cochin-Pasteur Paris, France

View Trial Details

Completed

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

NCT06387511

Conditions: Immunization Coverage, Infections, Malnutrition, +10 more
Locations: All Primary Health Care Centers of Nguru and Karasuwa LGAs Damaturu, Yobe State, Nigeria

View Trial Details

Completed

Predictors of Measles Vaccine Hesitancy in New York State

NCT07373093

Conditions: Infections, Measles, Measles Vaccination, +5 more
Locations: Albany Medical Albany, New York, United States

View Trial Details

Completed

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

NCT06399003

Conditions: Infections, Measles, Measles-Mumps-Rubella, +15 more
Locations: Victoria Biomedical Research Institute(VIBRI) Kisumu, Kenya

View Trial Details

Completed

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

NCT06331702

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +31 more
Locations: Jiangsu Provincial Center for Disease Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Completed

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

NCT03071575

Conditions: Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Icddr,B Chāndpur, Bangladesh

View Trial Details

Completed

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

NCT05630846

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Bellflower, California, United States

GSK Investigational Site Huntington Park, California, United States

View all 47 locations

View Trial Details

Completed

Barriers and Facilitators to MMR Vaccination Among Healthcare Workers

NCT06456788

Conditions: Infections, Measles, Mononegavirales Infections, +4 more
Locations: King's College London London, United Kingdom

View Trial Details

Completed

Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience

NCT05614791

Conditions: Infections, Measles, Mononegavirales Infections, +4 more
Locations: Esenler Maternity and Child Health Hospital Istanbul, Esenler, Turkey (Türkiye)

Haseki Training and Research Hospital Istanbul, Turkey (Türkiye)

View Trial Details